Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AZTA
HOLDAzenta, Inc. · Healthcare · United States · $1.3B · Avg Vol: $18M/d
COMPANY DESCRIPTION
Azenta, Inc. provides life sciences solutions, including automated sample management systems, consumables, and genomics services to pharmaceutical, biotech, and academic researchers. A leader in its field, its integrated solutions, proprietary automation, and global infrastructure improve research efficiency and reliability, creating a competitive advantage. Azenta is a pure-play life sciences technology company, well-positioned for growth in genomics and sample preservation.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 555.5M | 551.5M | 573.4M | 593.8M | 2.2% | 596.5M | 600.5M | 630.1M | 3.0% |
| EPS | 28.48 | -0.22 | -3.60 | -1.30 | — | -2.41 | — | — | — |
| Shares | 75.0M | 57.8M | 45.6M | 45.9M | -38.9% | 46.1M | — | — | — |
| Debt | 49.2M | 60.4M | 56.7M | 51.2M | 1.3% | 55.7M | — | — | — |
| Equity | 3.4B | 2.5B | 1.8B | 1.7B | -19.9% | — | — | — | — |
| Op CF | -466.0M | 5.8M | 49.7M | 72.2M | 251.7% | 62.3M | — | — | — |
| Inv CF | 1.5B | 431.4M | 224.7M | -90.5M | — | — | — | — | — |
| Fin CF | -62.8M | -840.5M | -659.2M | -9.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AZTA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AZTA | Azenta, Inc.(you) | $1.3B | 44 | HOLD |
| STAA | STAAR Surgical Company | $1.2B | 55 | HOLD |
| BLFS | BioLife Solutions, Inc. | $1.5B | 56 | HOLD |
| ATRC | AtriCure, Inc. | $1.8B | 55 | HOLD |
| WRBY | Warby Parker Inc. | $3.0B | 42 | HOLD |
| KMTS | Kestra Medical Technologies, Ltd. | $1.2B | 23 | SELL |
| PLSE | Pulse Biosciences, Inc. | $2.1B | 24 | SELL |
| ANGO | AngioDynamics, Inc. | $562M | 58 | HOLD |
| MMED | MiniMed Group, Inc. | $4.7B | 37 | HOLD |
| OSUR | OraSure Technologies, Inc. | $273M | 48 | HOLD |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%